Ashley Bridges
Family Medicine · Claremore, OKNPI 1487944427
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,181 and has fallen 51.5% since, to $573 in 2023.
Across 160 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$318
- AbbVie$292
- Johnson & Johnson$241
- AstraZeneca$183
- Pfizer$150
- Amgen$148
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,363100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $318 |
| AbbVie(2 entities) | 17 | $292 |
| Johnson & Johnson | 19 | $241 |
| AstraZeneca | 14 | $183 |
| Pfizer | 11 | $150 |
| Amgen(2 entities) | 8 | $148 |
| Lilly USA, LLC | 9 | $116 |
| Teva Pharmaceuticals USA, Inc. | 8 | $109 |
| Boehringer Ingelheim | 8 | $105 |
| Novartis | 5 | $97 |
| Astellas Pharma US Inc | 7 | $95 |
| GSK | 6 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $89 |
| Merck | 5 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Antares Pharma, Inc. | 2 | $31 |
| Corium, LLC | 1 | $24 |
| Medtronic | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Dexcom, Inc. | 1 | $12 |
| Ironshore Pharmaceuticals Inc. | 1 | $11 |
How this compares
$2,363 in reported general payments places this provider in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $89 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Claremore
- Brent HinkleClaremore$12K
- Seth NodineClaremore$12K
- Alexander FrankOklahoma City$3.1M
- Stanley ShadidEdmond$363K
- Geoffrey PlumleeTulsa$297K
- Curtis HarrisAda$125K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Lisa ConneryNorman$105K
- Michael RobinsonElk City$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.